Smithfield Trust Co - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Smithfield Trust Co ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$292
-12.6%
2,861
-13.7%
0.02%
-10.0%
Q2 2023$334
-24.8%
3,315
-31.2%
0.02%
-28.6%
Q1 2023$444
+1.1%
4,8150.0%0.03%
-6.7%
Q4 2022$439
-99.9%
4,815
-5.3%
0.03%
+7.1%
Q3 2022$386,000
-25.5%
5,085
-16.7%
0.03%
-22.2%
Q2 2022$518,000
+15.4%
6,101
+20.0%
0.04%
+24.1%
Q1 2022$449,000
-6.7%
5,085
-7.3%
0.03%
-3.3%
Q4 2021$481,000
+6.9%
5,4850.0%0.03%0.0%
Q3 2021$450,000
-10.0%
5,4850.0%0.03%
-9.1%
Q2 2021$500,000
+5.3%
5,485
-1.4%
0.03%0.0%
Q1 2021$475,000
-9.7%
5,5650.0%0.03%
-13.2%
Q4 2020$526,000
+8.7%
5,5650.0%0.04%
-2.6%
Q3 2020$484,000
-0.4%
5,5650.0%0.04%
-11.4%
Q2 2020$486,000
+4.1%
5,565
-1.9%
0.04%
-10.2%
Q1 2020$467,000
+719.3%
5,675
+838.0%
0.05%
+880.0%
Q4 2019$57,000
+7.5%
6050.0%0.01%0.0%
Q3 2019$53,000
-3.6%
6050.0%0.01%
-16.7%
Q2 2019$55,000
-21.4%
605
-17.1%
0.01%
-25.0%
Q1 2019$70,000
+11.1%
7300.0%0.01%
+14.3%
Q4 2018$63,0000.0%7300.0%0.01%0.0%
Q3 2018$63,000
+14.5%
7300.0%0.01%
+16.7%
Q2 2018$55,000
-42.7%
730
-38.7%
0.01%
-50.0%
Q1 2018$96,000
-15.8%
1,190
-12.5%
0.01%
-14.3%
Q4 2017$114,000
+17.5%
1,360
+20.9%
0.01%
+7.7%
Q3 2017$97,000
+110.9%
1,125
+102.7%
0.01%
+85.7%
Q2 2017$46,000
+12.2%
5550.0%0.01%
+16.7%
Q1 2017$41,000
-78.6%
555
-79.0%
0.01%
-81.2%
Q4 2016$192,000
-62.1%
2,640
-58.9%
0.03%
-64.4%
Q3 2016$506,000
-5.9%
6,418
-1.5%
0.09%
-10.9%
Q2 2016$538,000
+58.2%
6,518
+38.8%
0.10%
+53.0%
Q1 2016$340,000
+3677.8%
4,695
+4595.0%
0.07%
+3200.0%
Q4 2015$9,0000.0%1000.0%0.00%0.0%
Q3 2015$9,000
-10.0%
1000.0%0.00%0.0%
Q2 2015$10,0000.0%1000.0%0.00%0.0%
Q1 2015$10,000
+11.1%
1000.0%0.00%0.0%
Q4 2014$9,0000.0%1000.0%0.00%0.0%
Q3 2014$9,000
-50.0%
100
-50.0%
0.00%
-50.0%
Q2 2014$18,000
+5.9%
2000.0%0.00%
+33.3%
Q1 2014$17,000
+6.2%
2000.0%0.00%0.0%
Q4 2013$16,000
+6.7%
2000.0%0.00%0.0%
Q3 2013$15,000
-46.4%
200
-50.0%
0.00%
-57.1%
Q2 2013$28,0004000.01%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders